Dana-Farber Cancer Institute

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Dana-Farber Cancer Institute
Jan 23, 2025, 13:56 | Science
2 Neoadjuvant chemo-IO trials for high-risk ER+ BC
Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, shared an article by Fatima Cardoso…
Jan 23, 2025, 09:37 | Blog
Experiences and challenges of young adult patients with CRC - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Clinicians and researchers have recognized a disturbing…
Jan 22, 2025, 15:27 | Blog
The Future of Integrative Oncology: Bridging Cultures, Embracing Innovation and Fostering Unity - SIO
Society for Integrative Oncology shared a post on LinkedIn: "We are excited to announce the…
Jan 20, 2025, 02:16 | Science
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer
Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute, shared an article by Alicia F. C.…
Jan 19, 2025, 15:36 | Blog
Paolo Tarantino: How do you plan to use Datopotamab Deruxtecan for HR+/HER2- MBC?
Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute, shared a post on X: "Dato-DXd is…
Jan 18, 2025, 14:00 | Insight
2025 Transatlantic Exchange by Dana-Farber and Gustave Roussy to Focus on Radioligand Therapy
Dana-Farber Cancer Institute and Gustave Roussy (Villejuif, France) have announced the 2025 Transatlantic Exchange scientific…
Jan 16, 2025, 09:28 | Blog
Glenn J. Hanna: Multidisciplinary approach to treat HPV-driven oropharyngeal cancer
Glenn J. Hanna, Medical Oncologist and Physician at Dana-Farber Cancer Institute shared a post on…
Jan 16, 2025, 08:14 | Career
Narjust Florez was named as a health equity champion by Boston Business Journal
Florez Lab shared a post on X: “Narjust Florez has been named a Health Equity…
Jan 15, 2025, 14:29 | Blog
Findings related to CDK4/6 inhibitors and antibody drug conjugates presented at SABCS 2024 - Cancer Network
Cancer Network shared a post on X: "Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD…
Jan 15, 2025, 13:18 | Blog
Dana-Farber Cancer Institute - One of the first clinical trials in the US to test 'memory like' NK cells in ovarian cancer
Dana-Farber Cancer Institute shared on LinkedIn: "Investigators at Dana-Farber are opening a new clinical trial to…
Jan 15, 2025, 11:08 | Blog
Why Dana-Farber Direct Connect? - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "When it comes to cancer treatment, where…
Jan 15, 2025, 07:22 | Societies
Benjamin Ebert: Excited to launch the Center for RAS Therapeutics
Benjamin Ebert, President and CEO of Dana-Farber Cancer Institute, shared a post on LinkedIn by…
Jan 12, 2025, 15:08 | Blog
Dana-Farber Cancer Institute has been named one of Forbes' Top 100 Charities
The 2024 Forbes list of America’s Top 100 Charities highlights the significant impact of major…
Jan 10, 2025, 23:34 | Science
H. Moses Murdock: How I Treat AML relapse after allogeneic HCT
H. Moses Murdock, Hematology/Oncology fellow at Dana-Farber Cancer Institute, shared a post on X about…
Jan 10, 2025, 08:43 | Blog
Five Efforts by the Centers for Early Detection and Interception - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Dana-Farber’s Centers for Early Detection and Interception…
Jan 9, 2025, 15:58 | Insight
Dana-Farber Cancer Institute has officially launched the Center for RAS Therapeutics
RAS Therapeutics is a multidisciplinary initiative designed to enhance scientific research, improve treatment strategies, and…
Jan 6, 2025, 16:49 | Blog
Tackling Disparities in Childhood Cancer Outcomes: The IGNITE Consortium's Mission
Dr. Kira Bona and her team at the Dana-Farber lab have discovered a troubling truth:…
Jan 5, 2025, 17:42 | Career
Alexandra Bailey's journey to Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Four years ago, Alexandra Bailey, MD, received…
Jan 5, 2025, 17:04 | Career
William Hahn Named to Becker's Healthcare COOs to Know List
Dana-Farber Cancer Institute shared a post on LinkedIn: “Congratulations to William Hahn on being named…
Dec 28, 2024, 18:19 | Blog
Benjamin Ebert: Privileged to end this year a few months into my tenure as President and CEO of Dana-Farber Cancer Institute
Benjamin Ebert, President and CEO of Dana-Farber Cancer Institute, shared a post on LinkedIn: "With…
Dec 27, 2024, 18:27 | Blog
A CRISPR-based rapid molecular diagnostic for two forms of leukemia - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Researchers at Dana-Farber have created a CRISPR-based…
Dec 27, 2024, 07:50 | Blog
Ken Kehl: A new open-source approach to match patients with cancer to potential clinical trials
Ken Kehl, Assistant Professor of Medicine at Harvard Medical School and Physician at Dana-Farber Cancer…
Dec 24, 2024, 11:36 | Blog
How T-cells recognize foreign proteins has changed the way we think about the immune response
Dana-Farber Cancer Institute shared on LinkedIn: "'Humans are difficult,' said Mark Davis,  director of the Stanford…
Dec 23, 2024, 15:46 | Insight
Testing novel therapies in patients and in patient-derived organoids - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "In a treatment room in the Yawkey…
Dec 22, 2024, 05:13 | Blog
The Connell and O’Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "The Connell and O’Reilly Families Cell Manipulation…
Dec 21, 2024, 12:39 | Insight
Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer
Dan Nicolson, Director of Biopharma Business Development at Personalis, Inc., shared a post on Linkedin:…
Dec 21, 2024, 12:14 | Blog
Paolo Tarantino: Ending of a terrific 3-year cycle of PhD at The University of Milan
Paolo Tarantino, Research Fellow, Dana-Farber Cancer Institute, shared a post on LinkedIn: "Ending of a…
Dec 19, 2024, 07:27 | Insight
Geoffrey Shapiro Honored with MSCO Distinguished Researcher Award
Dana-Farber Cancer Institute shared a post on LinkedIn: “The Massachusetts Society of Clinical Oncologists (MSCO)…
Dec 19, 2024, 02:01 | Science
Paolo Tarantino: Time to move beyond the one-size-fits all paradigm for residual disease
Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared a post…
Dec 18, 2024, 18:42 | Blog
Antonio Giordano: Dana-Farber’s CCTI team expanding interests and growing with Glenn J. Hanna leadership
Antonio Giordano, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared a post on X: "Overly…
Dec 18, 2024, 16:11 | Blog
Paolo Tarantino: Proud to be part of international group of ESMO Ambassadors
Paolo Tarantino, PhD in clinical research at the University of Milan, shared a post on…
Dec 18, 2024, 12:25 | Career
OncoInfluencers to Follow on Social Media: Dr. Nancy Lin
We’re excited to feature Dr. Nancy Lin, a distinguished leader in breast cancer research and…
Dec 14, 2024, 19:28 | Blog
Association Between Risk-Reducing Surgeries and Survival in Young BRCA Carriers
Guilherme Nader Marta, Clinical Fellow at Dana-Farber Cancer Institute, shared a post on X: "Great…
Dec 14, 2024, 15:44 | Blog
Sara Tolaney: First line treatment approaches in HER2+ BC
Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, shared a…
Dec 13, 2024, 06:44 | Blog
Sara Tolaney: HER3DXd showed pCR and ORR rates similar to standard multi-agent chemotherapy
Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, shared a…
Dec 12, 2024, 15:40 | Blog
Sara Tolaney: DESTINY-Breast06 - Efficacy by pace of disease progression
Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, shared a…
Dec 12, 2024, 13:36 | Blog
Paolo Tarantino: What is the activity of different treatment regimens after progression on T-DXd for MBC?
Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute, posted on X: "What is the activity…
Dec 10, 2024, 19:22 | Blog
Kelly Meza: Meeting with Dr. Ruben A. Mesa at ASH24
Kelly Meza, Research Assistant at Dana-Farber Cancer Institute, recently shared a post on X: "Finally…
Dec 10, 2024, 11:06 | Insight
Dana-Farber Researchers to Present at the 2024 San Antonio Breast Cancer Symposium
Researchers from Dana-Farber Cancer Institute will present over 30 studies at the 47th Annual San…
Dec 6, 2024, 17:13 | Insight
Guilherme Nader Marta: RWE is becoming increasingly vital in cancer research
Guilherme Nader Marta, Clinical Fellow at Dana-Farber Cancer Institute, shared a post on X: “RWE…
Dec 4, 2024, 13:03 | Blog
Two Grand Rounds at Integrative Oncology Working Group
Integrative Oncology Working Group posted on LinkedIn: "IOWG will end 2024 with two outstanding GRAND…
Dec 4, 2024, 09:54 | Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024
Starting on August 26, in honor of Women’s Equality Day in the United States, which…
Dec 2, 2024, 22:27 | Insight
Survival Outcomes with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a recent article by Peter Schmid…
Dec 2, 2024, 18:09 | Insight
Paolo Tarantino: Excited to present the results of 4 studies at SABCS24
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X: “10 days to…
Nov 30, 2024, 23:26 | Insight
Is Carboplatin needed for the neoadjuvant treatment of HER2 positive Breast cancer?
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a recent by Xiu-Chun Chen on…
Nov 30, 2024, 16:39 | Blog
Registration is open for Part III of the AORTIC North America Series
AORTIC Africa shared a post on LinkedIn: "Have you registered for Part III of the…
Nov 30, 2024, 15:58 | Blog
Dana-Farber - Changing how outcomes of clinical trials are shared with patients by publishing summaries of trials
Dana-Farber shared on X: "The Breast Oncology Program is changing how outcomes of clinical trials are…
Nov 26, 2024, 13:22 | Blog
David Jackman addresses common lung cancer risk factors - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Smokers have a 20-fold increase in the…
Nov 25, 2024, 18:03 | Insight
Rutika Mehta: The 2nd Annual GI Cancer Summit
Rutika Mehta, Associate Professor at Weill Cornell Medicine, shared a post on X: “Thanks to…
Nov 25, 2024, 15:59 | Blog
Gastric Cancer Awareness Month 2024
November is Gastric Cancer Awareness Month, a time to raise awareness about gastric (stomach) cancer.…
Nov 24, 2024, 08:53 | Blog
Coleman Lindsley: Faculty position open at Dana-Farber Cancer Institute
Coleman Lindsley, Physician-Scientist at Dana-Farber Cancer Institute, shared the following on X: “We just opened a…
Nov 22, 2024, 17:22 | Insight
Chiara Corti: Estrogen Signaling in Early-Stage Breast Cancer
Chiara Corti, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: “I am…
Nov 20, 2024, 15:43 | Blog
Parts of The AORTIC North America Series - AORTIC- Africa
AORTIC- Africa shared a post on LinkedIn: "The AORTIC North America Series continues on 3 December…
Nov 20, 2024, 10:18 | Blog
Andrew Lane received the 2024 David M. Livingston Collaboration Award
Dr. Andrew A. Lane of Dana-Farber Cancer Institute was recognized with the David M. Livingston…
Nov 18, 2024, 16:36 | Insight
Very last chance to apply for the CancerX Accelerator Startup
CancerX Moonshot shared a post on LinkedIn: “Due tomorrow! This is your very last chance…
Nov 17, 2024, 09:56 | Blog
Toni Choueiri received the Lifetime Achievement Award at The King Hussein Cancer Foundation Annual Celebration
Toni Choueiri from Dana-Farber Cancer Institute Honored with Lifetime Achievement Award at The King Hussein…
Nov 17, 2024, 07:33 | Blog
Toni Choueiri: Honored by the King Hussein Cancer Foundation
Toni Choueiri, Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute,…
Nov 16, 2024, 20:35 | Insight
Kate Dibble: Financial Difficulty Over Time in Young Adults With Breast Cancer
Kate Dibble, Instructor of Medicine at Dana-Farber Cancer Institute, shared a post on X about…
Nov 14, 2024, 13:02 | Blog
Chiara Corti: We are officially oncologists!
Chiara Corti, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "Today, after…
Nov 13, 2024, 11:25 | Blog
Some information you should know about lung cancer - American Cancer Society
American Cancer Society shared on LinkedIn: "Some information you should know about lung cancer, from Dr.…
Nov 11, 2024, 04:28 | Blog
Dana-Farber Cancer Institute supports breast cancer equity legislation in Massachusetts
Dana-Farber Cancer Institute shared a post on LinkedIn: "This week, the state Legislature passed a…
Nov 11, 2024, 03:28 | Dialogues
Beyond the Cancer Diagnosis: Dialogue with Sue Morris, by Adrian Pogacian
In this edition of "Beyond the Cancer Diagnosis", Adrian Pogacian interviews clinical psychologist Sue Morris…
Nov 10, 2024, 15:29 | Blog
Save the date for the 22nd SIO International Conference
Society for Integrative Oncology posted on X: "Save the date! SIO is excited to partner…
Nov 9, 2024, 20:08 | Blog
Dr. Sara Tolaney Discusses ESMO24 Insights on TroFuse-010 Trial in Advanced Breast Cancer
Dana-Farber’s Breast Oncology Center shared the following on X: “Dr. Sara Tolaney discussed ESMO24 Insights…
Nov 9, 2024, 10:21 | Blog
Toni Choueiri: Our recent perspective on the next therapies in immuno-oncology trials
Toni Choueiri, Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, posted…
Nov 8, 2024, 13:58 | Blog
Rashad Nawfal: Our work on the landscape of subsequent therapies in perioperative Immuno-oncology trials
Rashad Nawfal, Postdoctoral Research Fellow at Dana Farber Cancer Institute, shared on X about recent…
Nov 8, 2024, 12:37 | Positive
Jennifer Buell: Pioneering Leadership in Biotechnology
Dr. Jennifer Buell is a prominent figure in the biotechnology industry, currently serving as the…
Nov 7, 2024, 15:50 | Insight
Endometrial Cancer Advances - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "For the past decade, new cases of endometrial…
Nov 6, 2024, 14:55 | Insight
Dana Farber Cancer Institute’s 7th Annual Inflammatory Breast Cancer Patient Forum
Dana-Farber’s Breast Oncology Center shared a post on X: “Join us on Saturday November 9…
Nov 6, 2024, 12:05 | Blog
Karl Semaan: Landscape of subsequent therapies in perioperative immunotherapy trials
Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber Cancer Institute, posted on X about recent…
Nov 4, 2024, 10:04 | Blog
Toni Choueiri: Cathy Wu and Patrick Ott were recognized as 2 of the leading cancer researchers by STAT
Toni Choueiri, Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute…
Nov 2, 2024, 12:01 | Positive
Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
As Pink October has ended, it's time to reflect on Breast Cancer Awareness Month. OncoDaily…
Oct 31, 2024, 16:35 | Blog
Does vaping increase your risk of cancer? - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Does vaping increase your risk of cancer?…
Oct 31, 2024, 08:36 | Blog
2024 Hamburg Awardees for Advances in Biomedical Research and Clinical Medicine - Dana-Farber Cancer Institute
Recently, Gordon Freeman and Arlene Sharpe Received the Hamburg Award from the National Academy of…
Oct 27, 2024, 09:14 | Blog
invIOs raises €8.2 million in a Series A to finance pipeline progress in immuno-oncology
invIOs GmbH, a privately held biotechnology company developing novel therapies for cancer, announced that the…
Oct 27, 2024, 08:17 | Blog
The 25th anniversary of pioneering Adult and Pediatric Patient and Family Advisory Councils - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: ''Last week we celebrated the 25th anniversary…
Oct 24, 2024, 17:26 | Blog
Recognizing Inflammatory Breast Cancer Awareness Day - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Today, Dr. Filipa Lynce, director of the Inflammatory…
Oct 24, 2024, 14:11 | Blog
How can you reduce your risk of cancer? - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute posted the following on LinkedIn: “If you’ve had a history of sunburns,…
Oct 23, 2024, 15:41 | Career
Matthew Vander Heiden is elected as a member of the National Academy of Medicine
Matthew Vander Heiden, Director of the Koch Institute for Integrative Cancer Research at MIT, was…
Oct 22, 2024, 23:13 | Blog
Announcing the 2025 CancerX Accelerator Program - CancerX Moonshot
CancerX Moonshot shared a post on LinkedIn: ''Announcing the 2025 CancerX Accelerator Program! This year,…
Oct 20, 2024, 18:47 | Blog
Tochukwu Njoku: A journey from uncertainty to confidence at Dana-Farber
Dana-Farber Cancer Institute shared the following on LinkedIn: “For Tochukwu Njoku, a period that started…
Oct 18, 2024, 15:17 | Drugs
Duffy - Null phenotype's impact on Cancer Drug Trials - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on Linkedin: '' Many clinical trials of new cancer drugs may…
Oct 17, 2024, 05:56 | Blog
Jun Mao: Amazing integrative medicine medical consult model of care Dana-Farber’s Breast Oncology Center
Jun Mao, Professor of Medicine at Weill Cornell Medicine, shared a post on X: “Seeing…
Oct 16, 2024, 17:00 | Insight
Biagio Ricciuti: 5-year update from the NADIM trial
Biagio Ricciuti shared a post on X about a recent paper by Mariano Provencio et…
Oct 16, 2024, 12:52 | Blog
Sylvia Bartel is the new senior vice president of pharmacy and chief pharmacy officer at Dana-Farber Cancer Institute
Sylvia Bartel is the chief pharmacy officer and senior vice president of pharmacy at the…
Oct 12, 2024, 17:13 | Career
Monica Bertagnolli: Humbled to become a Knight of the Order of Merit of the Republic of Italy
Monica Bertagnolli shared a post on LinkedIn: "I was humbled to recently receive the honor…
Oct 12, 2024, 00:58 | Blog
SIO partner with Dana Farber Cancer Institute in hosting the 22nd SIO International Conference
Society for Integrative Oncology (SIO) shared on X: '' Save the date! SIO is excited to…
Oct 11, 2024, 14:37 | Insight
U.S. FDA approved nivolumab with platinum-doublet chemotherapy
Toni Choueiri shared a post on X: "JUST IN: US_FDA approved nivolumab with platinum-doublet chemotherapy…
Oct 10, 2024, 06:38 | Insight
Guilherme Nader Marta: The impact of low levels of HER2 expression in the Ph3 PALLAS trial
Guilherme Nader Marta, Clinical Fellow at Dana-Farber Cancer Institute, recently shared about the Ph3 PALLAS…
Oct 9, 2024, 14:32 | Career
Toni Choueiri: Extremely well-deserved honor for Eli Van Allen on his Chair
Toni Choueiri shared a post about Eli Van Allen. Read his post on X below:…
Oct 9, 2024, 12:04 | Blog
Dana-Farber/Boston Children's ranked among the best pediatric cancer programs in the nation for 18th year in a row
Dana-Farber/Boston Children's Hospital Cancer and Blood Disorder Center has been recognized as one of the…
Oct 8, 2024, 12:41 | Blog
The Ending Metastatic Breast Cancer for Everyone Program - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on X: "Join Kristina Fanucci, MD, and Antonio Giordano, MD, PhD,…
Oct 7, 2024, 18:24 | Blog
Toni Choueiri: The mood for the 2024 The Jimmy Fund walk
Toni Choueiri shared a post on LinkedIn: "The mood in Hopkinton who is hosting us…
Oct 7, 2024, 17:05 | Blog
CRISPR-based mouse model for VHL-deficient clear cell kidney cancer shows promise, suggested by Yüksel Ürün
Yüksel Ürün shared an article by Laura A Stransky on X: "A new CRISPR-based mouse…
Oct 7, 2024, 11:35 | Blog
Carla Tardif: Children with cancer from low-income households are three times more likely to die and two times more likely to relapse than their counterparts
Carla Tardif shared a post on LinkedIn, about recent article published on her LinkedIn: ''Parents…
Oct 6, 2024, 17:16 | Blog
Do cancers always have a genetic component? - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on X: "Do cancers always have a genetic component?…
Oct 6, 2024, 15:28 | Insight
Revolutionizing Cancer Research: The Launch of the Cancer AI Alliance
Fred Hutch President Thomas Lynch announced the Cancer AI Alliance at the Madrona IA (Intelligent…
Oct 5, 2024, 16:52 | Blog
Breastfeeding experiences among young Breast Cancer survivors - ACS Journal Cancer
ACS Journal Cancer posted on X about recent paper by Tal Sella et al., titled…
Oct 5, 2024, 08:38 | Blog
Kimia Sorouri: Excited to be speaking at ASRM24
Kimia Sorouri, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "Excited to…
Oct 4, 2024, 15:15 | Blog
Paolo Tarantino: An interesting biomarker study of DB04. Two notable findings at ESMO24
Paolo Tarantino shared a post on X: "Among the many great ESMO24 posters there was…
All: 462 Posts: 1 - 100
Special Coverage